Certain antibodies in the blood and cerebrospinal fluid of healthy people, which Stanford University Medical Centre scientists have identified, may help prevent Alzheimer's disease.
They say that the levels of the antibodies found in healthy people decline with age and, in Alzheimer's patients, with increasing progression of the disease.
Alzheimer's disease is characterized by the build-up of amyloid plaques in the brain.
These are large aggregations of a protein breakdown product, or peptide, called A-beta....
↧